A polyp is an abnormal growth of tissue projecting from a mucous membrane. If it is attached to the surface by a narrow elongated stalk, it is said to be pedunculated. If no stalk is present, it is said to be sessile. Polyps are commonly found in the colon, stomach, nose, sinus(es), urinary bladder and uterus. They may also occur elsewhere in the body where mucous membranes exist like the cervix and small intestine.
! Polyp | ! Histologic appearance | ! Risk of malignancy | ! Picture | ! Syndromes |
Hyperplastic | Serrated unbranched crypts | None | Hyperplastic polyposis syndrome | |
Sessile serrated adenoma | Similar to hyperplastic with hyperserration, dilated/branched crypt base, prominent mucin cells at crypt base | |||
Inflammatory | Raised mucosa/submucosa with inflammation | If dysplasia develops | Inflammatory Bowel Disease, ulcers, infections, mucosal prolapse | |
Tubular Adenoma (Villous, Tubulovillous) | Tubular glands with elongated nuclei (at least low-grade atypia) | Yes | ||
Traditional Serrated Adenoma | Serrated crypts, often villous architecture, with cytologic atypia, eosinophilic cells | Yes | ||
Peutz-Jeghers Polyp | Smooth muscle bundles between nonneoplastic epithelium, "Christmas tree" appearance | No | Peutz–Jeghers syndrome | |
Juvenile Polyp | Cystically dilated glands with expanded lamina propria | Not inherently, may develop dysplasia | Juvenile polyposis syndrome, identical polyps in Cronkhite-Canada syndrome | |
Hamartomatous Polyp (Cowden Syndrome) | Variable; classical mildly fibrotic polyp with disorganized mucosa and splaying of muscularis mucosae; also inflammatory, juvenile, lipoma, ganglioneuroma, lymphoid | No | Cowden syndrome |
Most colon polyps can be categorized as sporadic.
About 50% of people aged 60 will have at least one adenomatous polyp of 1 cm diameter or greater. Multiple adenomatous polyps often result in familial polyposis coli or familial adenomatous polyposis, a condition that carries a very high risk of colon cancer.
Adenomas comprise approximately 10% of polyps. Most polyps (approximately 90%) are small, usually less than 1 cm in diameter, and have a small potential for malignancy. The remaining 10% of adenomas are larger than 1 cm and approach a 10% chance of containing invasive cancer.
There are three types of adenomatous polyps:
The risks of progression to colorectal cancer increases if the polyp is larger than 1 cm and contains a higher percentage of villous component. Also, the shape of the polyps is related to the risk of progression into carcinoma. Polyps that are pedunculated (with a stalk) are usually less concerning than sessile polyps (flat). Sessile polyps have a shorter pathway for migration of invasive cells from the tumor into submucosal and more distant structures, and they are also more difficult to remove and to ascertain. Sessile polyps larger than 2 cm usually contain villous features, have a higher malignant potential, and tend to recur following colonoscopic polypectomy.
Although polyps do not carry significant risk of colon cancer, tubular adenomatous polyps may become cancerous when they grow larger. Larger tubular adenomatous polyps have an increased risk of malignancy when larger because then they develop more villous components and may become sessile.
It is estimated that an individual whose parents have been diagnosed with an adenomatous polyp has a 50% greater chance to develop colon cancer than individuals with no family history of colonic polyps. At this point, there is no method to establish the risks that patients with a family history of colon polyps have to develop these growths. Overall, nearly 6% of the population, regardless of the family history, is at risk to developing colon cancer.
Screening for colonic polyps as well as preventing them has become an important part of the management of the condition. The American Cancer Society has established guidelines for colorectal screening in order to prevent adenomatous polyps and to minimize the chances of developing colon cancer. It is believed that some changes in the diet might be helpful in preventing polyps from occurring but there is no other way to prevent the polyps from developing into cancerous growths than by detecting and removing them.
According to the guidelines established by the American Cancer Society, individuals who reach the age of 40 should perform an occult blood test yearly. The colon polyps, as they grow might cause bleeding within the intestine which can be detected with the help of this test. Also, persons in their 50s are recommended to have flexible sigmoidoscopies performed once in 3 to 5 years to detect any abnormal growth which could be an adenomatous polyp. If adenomatous polyps are detected during this procedure, it is most likely that the patient will have to undergo a colonoscopy. However, colonoscopies are recommended by many physicians as an important part of screening for colon cancer as they provide an accurate image of the intestine and also allow the removal of the polyp, if found. Once an adenomatous polyp is identified during colonoscopy, there are several methods of removal including using a snare or a heating device. Colonoscopies are advised to be performed every 10 years in individuals who reached the age of 50 and who do not suffer from colonic polyps or cancer. Colonoscopies are preferred over sigmoidoscopies because they allow the examination of the entire colon, a very important aspect considering that more than half of the colonic polyps occur in the upper colon which is not reached during sigmoidoscopies.
It has been statistically proved that the screening programs are effective in reducing the number of deaths caused by colon cancer due to adenomatous polyps. Yet, although these tests are almost 100% safe, their use is still controversial because of the complications that might arise. However, most of the specialists agree that the benefits of colorectal screening overcome the risks. The risk of complications arising from colonoscopies is half the risk of developing colon cancer. As there is a small likelihood of recurrence, surveillance after polyp removal is recommended.
Category:Digestive system neoplasia Category:Gynaecology
de:Polyp (Geschwulst) es:Pólipo (medicina) fa:پولیپ fr:Polype (médecine) fy:Polyp (swolm) io:Polipo (medicino) it:Polipo (medicina) he:פוליפ (רפואה) kk:Полип nl:Poliep (gezwel) ja:ポリープ no:Polypp (medisin) pl:Polip (medycyna) pt:Pólipo (medicina) ru:Полип (медицина) fi:Polyyppi (lääketiede) sv:Polyper th:ติ่งเนื้อเมือก uk:Поліп (медицина) ur:سلیلہ (مرض)This text is licensed under the Creative Commons CC-BY-SA License. This text was originally published on Wikipedia and was developed by the Wikipedia community.
The World News (WN) Network, has created this privacy statement in order to demonstrate our firm commitment to user privacy. The following discloses our information gathering and dissemination practices for wn.com, as well as e-mail newsletters.
We do not collect personally identifiable information about you, except when you provide it to us. For example, if you submit an inquiry to us or sign up for our newsletter, you may be asked to provide certain information such as your contact details (name, e-mail address, mailing address, etc.).
When you submit your personally identifiable information through wn.com, you are giving your consent to the collection, use and disclosure of your personal information as set forth in this Privacy Policy. If you would prefer that we not collect any personally identifiable information from you, please do not provide us with any such information. We will not sell or rent your personally identifiable information to third parties without your consent, except as otherwise disclosed in this Privacy Policy.
Except as otherwise disclosed in this Privacy Policy, we will use the information you provide us only for the purpose of responding to your inquiry or in connection with the service for which you provided such information. We may forward your contact information and inquiry to our affiliates and other divisions of our company that we feel can best address your inquiry or provide you with the requested service. We may also use the information you provide in aggregate form for internal business purposes, such as generating statistics and developing marketing plans. We may share or transfer such non-personally identifiable information with or to our affiliates, licensees, agents and partners.
We may retain other companies and individuals to perform functions on our behalf. Such third parties may be provided with access to personally identifiable information needed to perform their functions, but may not use such information for any other purpose.
In addition, we may disclose any information, including personally identifiable information, we deem necessary, in our sole discretion, to comply with any applicable law, regulation, legal proceeding or governmental request.
We do not want you to receive unwanted e-mail from us. We try to make it easy to opt-out of any service you have asked to receive. If you sign-up to our e-mail newsletters we do not sell, exchange or give your e-mail address to a third party.
E-mail addresses are collected via the wn.com web site. Users have to physically opt-in to receive the wn.com newsletter and a verification e-mail is sent. wn.com is clearly and conspicuously named at the point of
collection.If you no longer wish to receive our newsletter and promotional communications, you may opt-out of receiving them by following the instructions included in each newsletter or communication or by e-mailing us at michaelw(at)wn.com
The security of your personal information is important to us. We follow generally accepted industry standards to protect the personal information submitted to us, both during registration and once we receive it. No method of transmission over the Internet, or method of electronic storage, is 100 percent secure, however. Therefore, though we strive to use commercially acceptable means to protect your personal information, we cannot guarantee its absolute security.
If we decide to change our e-mail practices, we will post those changes to this privacy statement, the homepage, and other places we think appropriate so that you are aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it.
If we make material changes to our e-mail practices, we will notify you here, by e-mail, and by means of a notice on our home page.
The advertising banners and other forms of advertising appearing on this Web site are sometimes delivered to you, on our behalf, by a third party. In the course of serving advertisements to this site, the third party may place or recognize a unique cookie on your browser. For more information on cookies, you can visit www.cookiecentral.com.
As we continue to develop our business, we might sell certain aspects of our entities or assets. In such transactions, user information, including personally identifiable information, generally is one of the transferred business assets, and by submitting your personal information on Wn.com you agree that your data may be transferred to such parties in these circumstances.